Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M GELFAND

Showing results (581-590 of 889) with videos related to

Pageof 89
Sort By:
The American Journal of Dermatopathology|September 17, 2024
Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host DiseaseSavannah M Alvarado, Olivia G Cohen, Katherine Lattanzio, et al.
The British Journal of Dermatology|July 7, 2023
Malignancy risk in patients with atopic dermatitis: a population-based cohort studyJoy Wan, Daniel B Shin, Maha N Syed, et al.
The Journal of Investigative Dermatology|May 15, 2007
Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patientsTamar Nijsten, David M Meads, John de Korte, et al.
The Journal of Investigative Dermatology|May 22, 2009
The risk of stroke in patients with psoriasisJoel M Gelfand, Erica D Dommasch, Daniel B Shin, et al.
The American Journal of Gastroenterology|December 1, 1995
Cyclosporin use in the precolectomy chronic ulcerative colitis patient: a community experience and its relationship to prospective and controlled clinical trials. Pacific Northwest Gastroenterology SocietyR Kozarek, C Bedard, D Patterson, et al.
Journal of the American Academy of Dermatology|June 29, 2012
The impact of psoriasis on 10-year Framingham riskNehal N Mehta, Parasuram Krishnamoorthy, YiDing Yu, et al.
Journal of the American Academy of Dermatology|January 1, 2005
The prevalence of psoriasis in African Americans: results from a population-based studyJoel M Gelfand, Robert S Stern, Tamar Nijsten, et al.
Pharmacoepidemiology and Drug Safety|May 3, 2013
Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009Maryam M Asgari, Jashin J Wu, Joel M Gelfand, et al.
JAMA Dermatology|May 30, 2013
Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials--replyJoel M Gelfand, Shuwei Wang, Junko Takeshita, et al.
Brain : a Journal of Neurology|December 17, 2019
Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented gliaJeffrey M Gelfand, Ariele L Greenfield, Matthew Barkovich, et al.
Pageof 89

Showing results (581-590 of 889) with videos related to

Sort By:
Pageof 89
The American Journal of Dermatopathology|September 17, 2024
Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host DiseaseSavannah M Alvarado, Olivia G Cohen, Katherine Lattanzio, et al.
The British Journal of Dermatology|July 7, 2023
Malignancy risk in patients with atopic dermatitis: a population-based cohort studyJoy Wan, Daniel B Shin, Maha N Syed, et al.
The Journal of Investigative Dermatology|May 15, 2007
Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patientsTamar Nijsten, David M Meads, John de Korte, et al.
The Journal of Investigative Dermatology|May 22, 2009
The risk of stroke in patients with psoriasisJoel M Gelfand, Erica D Dommasch, Daniel B Shin, et al.
The American Journal of Gastroenterology|December 1, 1995
Cyclosporin use in the precolectomy chronic ulcerative colitis patient: a community experience and its relationship to prospective and controlled clinical trials. Pacific Northwest Gastroenterology SocietyR Kozarek, C Bedard, D Patterson, et al.
Journal of the American Academy of Dermatology|June 29, 2012
The impact of psoriasis on 10-year Framingham riskNehal N Mehta, Parasuram Krishnamoorthy, YiDing Yu, et al.
Journal of the American Academy of Dermatology|January 1, 2005
The prevalence of psoriasis in African Americans: results from a population-based studyJoel M Gelfand, Robert S Stern, Tamar Nijsten, et al.
Pharmacoepidemiology and Drug Safety|May 3, 2013
Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009Maryam M Asgari, Jashin J Wu, Joel M Gelfand, et al.
JAMA Dermatology|May 30, 2013
Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials--replyJoel M Gelfand, Shuwei Wang, Junko Takeshita, et al.
Brain : a Journal of Neurology|December 17, 2019
Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented gliaJeffrey M Gelfand, Ariele L Greenfield, Matthew Barkovich, et al.
Pageof 89